World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
22435
World Ranking
10543
National Ranking
4577

Overview

Anna Gazumyan is affiliated with Rockefeller University in the United States and focuses primarily on research in medicine and immunology. Their work spans multiple subfields, notably infectious diseases, immunology, virology, molecular biology, and radiology, nuclear medicine, and imaging.

Their research extensively covers a range of topics related to viral infections and immune responses. Key research themes include:

  • SARS-CoV-2 and COVID-19 research
  • Immunotherapy and immune responses
  • COVID-19 clinical research studies
  • T-cell and B-cell immunology
  • Monoclonal and polyclonal antibodies research
  • Immune cell function and interaction
  • HIV research and treatment

Gazumyan has contributed to various high-impact journals, frequently publishing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Experimental Medicine
  • Nature
  • Proceedings of the National Academy of Sciences
  • Immunity

Recent publications authored or co-authored by Gazumyan include:

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals, 2020, Nature
  • Evolution of antibody immunity to SARS-CoV-2, 2021, Nature
  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, 2021, Nature
  • Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, 2020, eLife
  • Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection, 2021, Nature

Gazumyan regularly collaborates with several researchers within their field. Frequent co-authors include:

  • Michel C. Nussenzweig
  • Thiago Y. Oliveira
  • Víctor Ramos
  • Théodora Hatziioannou
  • Paul D. Bieniasz

Best Publications

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

    Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi

  • Evolution of antibody immunity to SARS-CoV-2.

    Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch

  • Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

    Yiska Weisblum;Fabian Schmidt;Fengwen Zhang;Justin DaSilva

  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

    Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch

  • Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

    Zijun Wang;Frauke Muecksch;Dennis Schaefer-Babajew;Shlomo Finkin

  • Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

    Fabian Schmidt;Yiska Weisblum;Frauke Muecksch;Hans-Heinrich Hoffmann

  • MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation

    Yair Dorsett;Kevin M. McBride;Mila Jankovic;Anna Gazumyan;Anna Gazumyan

  • Enhanced SARS-CoV-2 neutralization by dimeric IgA.

    Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch;Shlomo Finkin

  • Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

    Ariel Halper-Stromberg;Ching-Lan Lu;Florian Klein;Joshua A. Horwitz

  • Activation-Induced Cytidine Deaminase Targets DNA at Sites of RNA Polymerase II Stalling by Interaction with Spt5

    Rushad Pavri;Anna Gazumyan;Anna Gazumyan;Mila Jankovic;Michela Di Virgilio

  • Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo

    Ching-Lan Lu;Ching-Lan Lu;Dariusz K. Murakowski;Stylianos Bournazos;Till Schoofs

  • Early antibody therapy can induce long-lasting immunity to SHIV

    Yoshiaki Nishimura;Rajeev Gautam;Tae-Wook Chun;Reza Sadjadpour

  • Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

    Masashi Shingai;Olivia K. Donau;Ronald J. Plishka;Alicia Buckler-White

  • Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

    Davide F. Robbiani;Leonia Bozzacco;Jennifer R. Keeffe;Ricardo Khouri

  • Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice

    Amelia Escolano;Jon M. Steichen;Pia Dosenovic;Daniel W. Kulp

  • A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

    Rajeev Gautam;Yoshiaki Nishimura;Amarendra Pegu;Martha C. Nason

  • Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.

    Alexandra Schäfer;Frauke Muecksch;Julio C.C. Lorenzi;Sarah R. Leist

  • 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination

    Anne Bothmer;Davide F. Robbiani;Niklas Feldhahn;Anna Gazumyan

  • Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.

    I Schwartz;G P Wormser;J J Schwartz;D Cooper

  • Evolution of Antibody Immunity to SARS-CoV-2

    Christian Gaebler;Zijun Wang;Julio C C Lorenzi;Frauke Muecksch

Frequent Co-Authors

Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Davide F. Robbiani
Davide F. Robbiani Universita della Svizzera Italiana
Paul D. Bieniasz
Paul D. Bieniasz Rockefeller University
Thiago Y. Oliveira
Thiago Y. Oliveira Rockefeller University
Pamela J. Bjorkman
Pamela J. Bjorkman California Institute of Technology
Marina Caskey
Marina Caskey Rockefeller University
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Charles M. Rice
Charles M. Rice Rockefeller University
Theodora Hatziioannou
Theodora Hatziioannou Rockefeller University
Victor A. Ramos
Victor A. Ramos University of Buenos Aires

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA can open doors to exciting online degree programs and fast-growing professional fields. For those interested in the intersection of science and business, pursuing an mba healthcare management online program is a strategic option. These degrees help equip students with leadership and management skills tailored for the healthcare sector.

Another career pathway involves healthcare data and administration roles. For instance, you can become a certified professional coder, a vital position that ensures accurate medical coding for billing and insurance purposes. Carefully comparing different certifications, such as CPC vs. CCS, can guide your decision depending on your career goals.

Salary prospects are promising in this field. To learn more about the earning potential, check out the latest figures for certified medical coder salary—which vary based on credentials, location, and experience.

If you are considering administrative roles, explore whether is medical billing and coding a good career for you. This can help you weigh the benefits and challenges, as well as understand growth opportunities in this dynamic sector.

Best Scientists Citing Anna Gazumyan

Trending Scientists